跳至主要内容
临床试验/NCT05033119
NCT05033119已完成不适用

PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

Ulla Schierup Nielsen5 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2021年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
5
主要终点
Prevalence of hyperprolactinemia

研究概览

简要总结

The objectives of this study are:

  1. To determine the prevalence and degree of hyperprolactinemia in children and adolescents aged 7-18 years receiving antipsychotic medications
  2. To determine the associations between serum-prolactin and sex hormones / metabolic biomarkers/ clinical symptoms in this population. If clinically relevant associations are found: To determine a potentially existing "no harm" serum-prolactin threshold
  3. To determine associations between previous cumulative prolactin-exposure and current pubertal development / growth

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
7 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • • In daily treatment with antipsychotic medication belonging to Anatomical Therapeutic Chemical (ATC) group N05A (except N05AN lithium) for a minimum duration of 3 months prior to inclusion

排除标准

  • Eating Disorder
  • Medical treatment to change sex
  • Pregnancy or lactation

结局指标

主要结局

Prevalence of hyperprolactinemia

时间窗: 2 years

次要结局

  • associations between serum-prolactin and sex hormones / metabolic biomarkers / clinical symptoms(2 years)
  • associations between previous prolactin-exposure and current pubertal development / growth(2 years)

研究者

发起方
Ulla Schierup Nielsen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ulla Schierup Nielsen

National Coordinating Principal Investigator

Aalborg University Hospital

研究点 (5)

Loading locations...

相似试验